Sartorius Stedim Biotech S.A.
SDMHF
$192.00
$0.500.26%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | 32.68% | -21.36% | -43.54% | |
| Total Depreciation and Amortization | -- | 5.19% | 12.43% | 21.69% | |
| Total Amortization of Deferred Charges | -- | 77.05% | 77.05% | 77.05% | |
| Total Other Non-Cash Items | -- | 73.29% | 405.81% | 1,009.17% | |
| Change in Net Operating Assets | -- | -26.80% | 42.23% | 31.70% | |
| Cash from Operations | -- | 12.33% | 37.55% | 9.31% | |
| Capital Expenditure | -- | 26.85% | 37.31% | 28.27% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | 99.95% | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 97.60% | 97.60% | 97.60% | |
| Cash from Investing | -- | 88.84% | 89.24% | 87.58% | |
| Total Debt Issued | -- | -99.32% | -99.30% | -99.35% | |
| Total Debt Repaid | -- | 95.44% | 60.73% | -169.36% | |
| Issuance of Common Stock | -- | -99.41% | -99.51% | 35,123.53% | |
| Repurchase of Common Stock | -- | 66.10% | -426.67% | -180.95% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -5.44% | -- | 49.25% | |
| Other Financing Activities | -- | -8.34% | -49.79% | 13.40% | |
| Cash from Financing | -- | -111.13% | -121.22% | -95.67% | |
| Foreign Exchange rate Adjustments | -- | 84.91% | 286.37% | 814.27% | |
| Miscellaneous Cash Flow Adjustments | -- | -107.64% | -51.63% | -0.28% | |
| Net Change in Cash | -- | -30.41% | -98.24% | 5,728.80% | |